Israeli medical device company for aesthetic, surgical and ophthalmic applications Lumenis Ltd. has completed the acquisition of Israeli medical aesthetic company Pollogen Ltd.. No financial details about the deal were disclosed. Lumenis CEO Tzipi Ozer-Armon said, “This transaction complements our aesthetic product portfolio and positions Lumenis well in the dynamic beauty market. The addition of Pollogen’s extensive portfolio is key to continuing to provide tailored and innovative beauty solutions to all of our existing and future aesthetic customers.”
Pollogen develops and manufactures advanced technologies with full-lines of clinically-proven, non-invasive anti-aging facial and body contouring treatment platforms for a spectrum of aesthetic applications. Lumenis says that Pollogen will strengthen its position in the beauty segment with its advanced solutions with a focus on radio-frequency technology.
Pollogen chairman and co-founder Zion Azar said. “Over the past 10 years, Pollogen has built a leading position in the aesthetic beauty market based on a culture of innovation and pioneering research. We are thrilled to join the Lumenis team and further develop our products and presence in this rapidly developing market.”
In June, China's XIO Group acquired Lumenis for $510 million. The Israeli company then delisted from Nasdaq.
Published by Globes [online], Israel business news - www.globes-online.com - on November 3, 2015
© Copyright of Globes Publisher Itonut (1983) Ltd. 2015